For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Gigagen, Inc.

USPTO Granted Patents = 22

EPO Patents = 4

Trademarks = 4

Forward Citations = 41

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

David Scott Johnson (22 out of 29 patents)

Adam Shultz Adler (16 out of 21 patents)

Rena Aviva Mizrahi (16 out of 18 patents)

4. Everett Hurteau Meyer (6 out of 13 patents)

5. Matthew James Spindler (5 out of 8 patents)

6. Yoong Wearn Lim (5 out of 9 patents)

7. Michael Asensio (5 out of 8 patents)

8. Sheila Keating (4 out of 4 patents)

9. Kacy Stadtmiller (3 out of 3 patents)

10. Angelica V Medina-Cucurella (3 out of 3 patents)

11. Ariel Niedecken (3 out of 3 patents)

12. Emily Benzie (3 out of 3 patents)

13. Jackson Leong (1 out of 1 patent)

14. Erica Lyn Stone (1 out of 1 patent)

15. Renee Leong (1 out of 1 patent)

22 patents: Sort by Forward Citations

1. 12590386 - Recombinant polyclonal proteins and methods of use thereof (2026-03-31),

2. 12421311 - Anti-CTLA-4 binding proteins and methods of use thereof (2025-09-23),

3. 12404607 - Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof (2025-09-02),

4. 12241178 - Recombinant fusion proteins and libraries from immune cell repertoires (2025-03-04),

5. 12195880 - Systems and methods for massively parallel combinatorial analysis of single cells (2025-01-14),

6. 11718660 - Recombinant polyclonal proteins targeting Zika and methods of use thereof (2023-08-08),

7. 11702765 - Recombinant fusion proteins and libraries from immune cell repertoires (2023-07-18),

8. 11685779 - Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof (2023-06-27),

9. 11591652 - System and methods for massively parallel analysis of nucleic acids in single cells (2023-02-28),

10. 11441240 - Systems and methods for massively parallel combinatorial analysis of single cells (2022-09-13),

11. 11427933 - Systems and methods for massively parallel combinatorial analysis of single cells (2022-08-30),

12. 11111490 - Systems and methods for massively parallel combinatorial analysis of single cells (2021-09-07),

13. 11053543 - System and methods for massively parallel analysis of nucleic acids in single cells (2021-07-06),

14. 10787706 - System and methods for massively parallel analysis of nucleic acids in single cells (2020-09-29),

15. 10689641 - Recombinant fusion proteins and libraries from immune cell repertoires (2020-06-23),

Company Overview

Gigagen, Inc. is a biotechnology company based in South San Francisco, California, specializing in the development of advanced genomic technologies. The organization focuses on harnessing the power of genetic data to enhance therapeutic solutions and improve patient outcomes. With a commitment to innovation, Gigagen aims to transform the landscape of personalized medicine through its cutting-edge research in genomics and bioinformatics, addressing critical challenges in healthcare and disease management.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

22 Patents

#59 in South San Francisco, CA

#3,590 in California

#15,051 in US

#28,807 in the World

South San Francisco, CA, United States of America

Gigagen, Inc.

Forward Citations = 41

15 inventors:

David Scott Johnson (22 out of 29 patents)

Adam Shultz Adler (16 out of 21 patents)

Rena Aviva Mizrahi (16 out of 18 patents)

4. Everett Hurteau Meyer (6 out of 13 patents)

5. Matthew James Spindler (5 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gigagen, Inc.. Retrieved from https://idiyas.com/company/gigagen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…